Indication
For the treatment of Friedreich’s ataxia (FA) in adults and adolescents aged 16 years and older.
Medicine details
- Medicine name:
- omaveloxolone (Skyclarys)
- SMC ID:
- SMC2845
- Pharmaceutical company
- Biogen
- BNF chapter
- Central nervous system
- Submission type
- Full
- Publication due date:
- 09 March 2026
- SMC meeting date:
- 03 February 2026
- Patient group submission deadline:
- TBC